Terakawa M - Search Results

1

CpG oligodeoxynucleotide prolongs eosinophil survival through activation of contaminating B cells and plasmacytoid dendritic cells in vitro.

Matsumoto K, Terakawa M, Fukuda S, Kato A, Toki S, Shinohara M, Wakiguchi H, Saito H. Matsumoto K, et al. Among authors: terakawa m. Int Arch Allergy Immunol. 2006;140 Suppl 1:42-50. doi: 10.1159/000092710. Epub 2006 Jun 9. Int Arch Allergy Immunol. 2006. PMID: 16772726

2

Rapid and strong induction of apoptosis in human eosinophils by anti-CD30 mAb-coated microspheres and phagocytosis by macrophages.

Matsumoto K, Terakawa M, Fukuda S, Saito H. Matsumoto K, et al. Among authors: terakawa m. Int Arch Allergy Immunol. 2007;143 Suppl 1:60-7. doi: 10.1159/000101407. Epub 2007 May 1. Int Arch Allergy Immunol. 2007. PMID: 17541279

3

Analysis of signal transduction pathways involved in anti-CD30 mAb-induced human eosinophil apoptosis.

Matsumoto K, Terakawa M, Fukuda S, Saito H. Matsumoto K, et al. Among authors: terakawa m. Int Arch Allergy Immunol. 2010;152 Suppl 1:2-8. doi: 10.1159/000312119. Epub 2010 Jun 4. Int Arch Allergy Immunol. 2010. PMID: 20523057

4

Extremely rapid and intense induction of apoptosis in human eosinophils by anti-CD30 antibody treatment in vitro.

Matsumoto K, Terakawa M, Miura K, Fukuda S, Nakajima T, Saito H. Matsumoto K, et al. Among authors: terakawa m. J Immunol. 2004 Feb 15;172(4):2186-93. doi: 10.4049/jimmunol.172.4.2186. J Immunol. 2004. PMID: 14764685

5

NR4A orphan nuclear receptor family in peripheral blood eosinophils from patients with atopic dermatitis and apoptotic eosinophils in vitro.

Kagaya S, Hashida R, Ohkura N, Tsukada T, Sugita Y, Terakawa M, Tsujimoto G, Katsunuma T, Akasawa A, Matsumoto K, Saito H. Kagaya S, et al. Among authors: terakawa m. Int Arch Allergy Immunol. 2005;137 Suppl 1:35-44. doi: 10.1159/000085430. Epub 2005 Jun 2. Int Arch Allergy Immunol. 2005. PMID: 15947483

6

Eosinophil migration induced by mast cell chymase is mediated by extracellular signal-regulated kinase pathway.

Terakawa M, Tomimori Y, Goto M, Hayashi Y, Oikawa S, Fukuda Y. Terakawa M, et al. Biochem Biophys Res Commun. 2005 Jul 15;332(4):969-75. doi: 10.1016/j.bbrc.2005.04.172. Biochem Biophys Res Commun. 2005. PMID: 15919053

7

Mast cell chymase induces expression of chemokines for neutrophils in eosinophilic EoL-1 cells and mouse peritonitis eosinophils.

Terakawa M, Tomimori Y, Goto M, Fukuda Y. Terakawa M, et al. Eur J Pharmacol. 2006 May 24;538(1-3):175-81. doi: 10.1016/j.ejphar.2006.03.053. Epub 2006 May 9. Eur J Pharmacol. 2006. PMID: 16690053

8

Oral chymase inhibitor SUN13834 ameliorates skin inflammation as well as pruritus in mouse model for atopic dermatitis.

Terakawa M, Fujieda Y, Tomimori Y, Muto T, Tanaka T, Maruoka H, Nagahira K, Ogata A, Nakatsuka T, Fukuda Y. Terakawa M, et al. Eur J Pharmacol. 2008 Dec 28;601(1-3):186-91. doi: 10.1016/j.ejphar.2008.10.040. Epub 2008 Oct 29. Eur J Pharmacol. 2008. PMID: 18996112

9

Epitope mapping of monoclonal antibodies to tumor necrosis factor-alpha by synthetic peptide approach.

Nagahira K, Fukuda Y, Terakawa M, Hashino J, Nasu T, Nakazato H, Nakanishi T. Nagahira K, et al. Among authors: terakawa m. Immunol Lett. 1995 May;46(1-2):135-41. doi: 10.1016/0165-2478(95)00031-y. Immunol Lett. 1995. PMID: 7590909

10

G protein-coupled receptor 39 plays an anti-inflammatory role by enhancing IL-10 production from macrophages under inflammatory conditions.

Muneoka S, Goto M, Kadoshima-Yamaoka K, Kamei R, Terakawa M, Tomimori Y. Muneoka S, et al. Among authors: terakawa m. Eur J Pharmacol. 2018 Sep 5;834:240-245. doi: 10.1016/j.ejphar.2018.07.045. Epub 2018 Jul 24. Eur J Pharmacol. 2018. PMID: 30053407

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

86 results

Search Page

Filters